References
- Bonini S, Bonini S, Lambiase A, et al. Vernal Keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophtalmology 2000;107:1157–1163
- Leonardi A, De Franchis G, Zancanaro F, et al. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest Ophthalmol Vis Sci 1999;40:3036–3040
- Kumar S. Vernal Keratoconjunctivitis: a major review. Acta Ophthalmologica 2009;87:133–147
- Nebbioso M, Zicari AM, Lollobrigida V. Assessment of corneal alterations by confocal microscopy in vernal keratoconjunctivitis. Seminars in Ophthalmology 2013 Sep 27:1--4. [Ahead of print]. Doi:10.3109/08820538.2013.821508
- Avunduk AM, Avunduk MC, Kapicioglu Z, et al. Mechanism and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis. Ophthalmology 2000;107:1333–1337
- Pucci N, Novembre E, Cianferoni A, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Annals of Allergy, Asthma & Immunology 2002;89:298–302
- El-Asrar AMA, Tabbara KF, Geboes K, et al. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis. Ocul Immunol Inflamm 1994;2:S17–S39
- Nussenblatt RB, Palestine AG. Cyclosporin: immunology, pharmacology and therapeutic uses. Surv Ophthalmol 1986;31:159–169
- Tatlipinar S, Akpek EK. Topical ciclosporin in the treatment of ocular surface disorders. Br J Ophthalmol 2005;89:1363–1367
- Holland EJ, Olsen TW, Ketcham JM, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993;12:413–419
- Pescosolido N, Komaiha C, Dapoto L, et al. Corneal haze in course of Fuchs' Endothelial Dystrophy. Clin Ter 2012;163(4):e169–171
- Bonini S, Lambiase A, Schiavone M, et al. Estrogen and progesterone receptors in vernal keratoconjunctivitis. Ophthalmology 1995;102:1374–1379
- Zicari AM, Nebbioso M, Lollobrigida V, et al. Vernal keratoconjunctivitis: atopy and autoimmunity. Eur Rev Med Parmacol Sci 2013;17(10):1419–1423
- Friedlaender MH. Ocular allergy. Seminars in Ophthalmology 1996;11:69–78
- Power WJ, Foster CS. Basic ocular immunology. Seminars in Ophthalmology 1996;11:3–9
- Zicari AM, Nebbioso M, Zicari A, et al. Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report. Eur Rev Med Parmacol Sci 2013;17(9):1242–1244
- Böhringer D, Birnbaum F, Reinhard T. Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis. Ophthalmologe 2008;105:592–594
- Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor beta 2 production. Cornea 2008;27:64–69
- Nochez Y, Denoyer A, Pisella PJ. 0.05% cyclosporine A for treatment of chronic severe ocular surface disease. Can J Ophthalmol 2009;44:406–411
- Nebbioso M, Belcaro G, Komaiha C, et al. Keratoconjunctivitis by confocal microscopy after topical cyclosporine. Panminerva Med. 2012;Nov 9:1–5 . [Epub ahead of print]